Profarma Distribuidora de Produtos Farmacêuticos S.A (PFRM3) — Strategic Asset Allocation Index
Profarma Distribuidora de Produtos Farmacêuticos S.A (PFRM3) has a Strategic Asset Allocation Index of 45.9% as of September 2025. Strategic assets (PP&E of R$767.48 Million plus long-term investments of R$-) total R$767.48 Million, measured against net assets of R$1.67 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Profarma Distribuidora de Produtos Farma liquidity resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Profarma Distribuidora de Produtos Farmacêuticos S.A Strategic Asset Allocation Index (2003–2024)
This chart shows how Profarma Distribuidora de Produtos Farmacêuticos S.A's Strategic Asset Allocation Index has evolved across 22 annual periods from 2003 to 2024. As of September 2025, the index stands at 45.9%, representing strategic assets of R$767.48 Million against net assets of R$1.67 Billion BRL. See Profarma Distribuidora de Produtos Farma (PFRM3) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Profarma Distribuidora de Produtos Farmacêuticos S.A (2003–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Profarma Distribuidora de Produtos Farmacêuticos S.A from 2003 to 2024, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see PFRM3 market cap.
| Year | SAAI | Strategic Assets (BRL) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 42.5% | R$674.18 Million | R$674.18 Million | R$- | R$1.59 Billion | ▲ +7.7 pp |
| 2023 | 34.8% | R$535.59 Million | R$535.59 Million | R$- | R$1.54 Billion | ▲ +1.2 pp |
| 2022 | 33.6% | R$507.00 Million | R$507.00 Million | R$- | R$1.51 Billion | ▼ -1.6 pp |
| 2021 | 35.2% | R$519.02 Million | R$519.02 Million | R$- | R$1.48 Billion | ▲ +7.8 pp |
| 2020 | 27.4% | R$392.62 Million | R$392.62 Million | R$- | R$1.44 Billion | ▼ -6.8 pp |
| 2019 | 34.2% | R$343.19 Million | R$310.83 Million | R$32.36 Million | R$1.00 Billion | ▲ +18.6 pp |
| 2018 | 15.5% | R$158.67 Million | R$128.90 Million | R$29.77 Million | R$1.02 Billion | ▼ -13.0 pp |
| 2017 | 28.5% | R$212.70 Million | R$136.01 Million | R$76.69 Million | R$745.93 Million | ▲ +3.2 pp |
| 2016 | 25.3% | R$191.89 Million | R$112.07 Million | R$79.82 Million | R$758.96 Million | ▲ +5.3 pp |
| 2015 | 20.0% | R$133.37 Million | R$74.84 Million | R$58.52 Million | R$667.95 Million | ▲ +0.6 pp |
| 2014 | 19.4% | R$133.71 Million | R$52.91 Million | R$80.80 Million | R$688.85 Million | ▲ +1.5 pp |
| 2013 | 17.9% | R$102.47 Million | R$45.48 Million | R$56.98 Million | R$571.56 Million | ▲ +12.0 pp |
| 2012 | 5.9% | R$33.90 Million | R$33.90 Million | R$- | R$570.93 Million | ▲ +0.1 pp |
| 2011 | 5.8% | R$31.60 Million | R$31.60 Million | R$- | R$541.47 Million | ▲ +0.4 pp |
| 2010 | 5.4% | R$28.26 Million | R$28.26 Million | R$- | R$518.89 Million | ▼ -0.2 pp |
| 2009 | 5.6% | R$27.22 Million | R$27.22 Million | R$- | R$485.37 Million | ▲ +1.2 pp |
| 2008 | 4.4% | R$20.42 Million | R$20.42 Million | R$- | R$467.44 Million | ▲ +1.0 pp |
| 2007 | 3.4% | R$15.04 Million | R$15.04 Million | R$- | R$443.42 Million | ▲ +1.3 pp |
| 2006 | 2.1% | R$8.47 Million | R$8.47 Million | R$- | R$404.47 Million | ▼ -5.7 pp |
| 2005 | 7.8% | R$6.26 Million | R$6.26 Million | R$- | R$79.95 Million | ▼ -3.8 pp |
| 2004 | 11.7% | R$7.89 Million | R$7.89 Million | R$- | R$67.69 Million | ▼ -3.3 pp |
| 2003 | 14.9% | R$7.79 Million | R$7.79 Million | R$- | R$52.29 Million | — |